Table 3. Specific systemic treatment established after immunological diagnosis of PV.
| Specific systemic treatment | No. of patients | % |
|---|---|---|
| Prednisone | 8 | 53.3 |
| Dapsone | 7 | 46.7 |
| Methotrexate | 4 | 26.7 |
| Azathioprine | 3 | 20 |
| Cyclophosphamide | 3 | 20 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.